Select Bibliography

Filter by any of these (after searching):

Hoke, Eva

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2 items

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Kolitz, Jonathan E. , George, Stephen L. , Marcucci, Guido ... - - Blood - 2010

Manuscript - Primary - Primary - Leukemia - CALGB-19808 , CALGB-8461

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101

Lin, Thomas S. , Donohue, Kathleen A. , Byrd, John C. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Leukemia - CALGB-10101